U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT06961279) titled 'Resveratrol Stimulates Insulin Sensitivity in Subjects With Obesity and Insulin Resistance' on April 29.
Brief Summary: There is evidence that resveratrol can improve insulin resistance in rodents and humans with obesity and it can also improve muscle mitochondrial content mediated through activation of AMPK. However, little is known if this improvement is associated with changes in the gut microbiota and how gut microbiota is associated with serum metabolites after consumption of resveratrol. In the present study, the investigators show that the consumption of resveratrol for 2 months could influence insulin sensitivity in subjects w...